Can Ocugen Overcome This Major Hurdle?

Can Ocugen Overcome This Major Hurdle?

Ocugen (NASDAQ: OCGN) is the biotech stock everyone's been talking about these past few months. The company made a splash when it said it was partnering with India's Bharat Biotech to bring an almost-ready coronavirus vaccine candidate to the U.S. market. As a result, Ocugen's shares have soared more than 400% so far this year.